Join our directors of bio-sciences, chemistry, and medicine Cameron English, Dr. Josh Bloom, and Dr. Chuck Dinerstein as they break down these stories on episode 23 of the Science Dispatch podcast.
Wanna hear something sickening? Neurontin, a drug developed for epilepsy and used off-label for neuropathic pain, had its sales grow 250% between 2004 and 2019. Why? We don't have 250% more epileptics. No, it's because the drug is being forced down the throats of people who can no longer get sufficient pain relief. The result? Abuse and also more overdose deaths. Just another chapter in our psychotic war against legitimate opioid drugs and the people who need them.
Continuing its trend of unjustified censorship, Twitter put a "warning" on one of our recent tweets "so people who don’t want to see sensitive content can avoid it." This protects nobody, but it denies the public access to credible health information.
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
Cameron English
Director of Bioscience
Cameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project.
